ArticleAlcohol, clinical & experimental research2023
Fuel to the fire: The impact of COVID-19 on alcohol-associated hepatitis.
Shreya Sengupta, Srinivasan Dasarathy
Abstract read
In one paragraphArticle in Alcohol, clinical & experimental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors.
Shreya SenguptaDepartments of Gastroenterology, Hepatology, and Nutrition, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Funding
Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Jonathan Mark Brown · 2016 to 2026
$19.6MProspective evaluation of outcomes in cirrhosis of different etiologies: impact of HIV infection and simvastatin therapyU01DK130180 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI Srinivasan Dasarathy · 2021 to 2026
$3.9MIntegrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD)- Cleveland Clinic Clinical CenterU01AA026976 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Srinivasan Dasarathy, David Streem · 2018 to 2026
$3.2MNovel mechanism based treatment to improve tissue injury in alcoholic hepatitisR01AA028190 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, NAGY, LAURA E. · 2020 to 2024
$2.8MUsing patient-level decision modeling to improve use of treatments for alcohol use disorderR01AA030970 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Phuc Le · 2023 to 2026
$2.6MSarcopenia in cirrhosis is mediated by a hyperammonemic stress responseR01DK113196 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, HATZOGLOU, MARIA · 2018 to 2021
$2.3MModeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes PatientsR01HS026937 · AHRQ · CLEVELAND CLINIC FOUNDATION · PI DASARATHY, SRINIVASAN, ROTHBERG, MICHAEL B · 2020 to 2024
$1.9MMechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01DK083414 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2011 to 2015
$1.8MNovel therapeutics for alcoholic hepatitis - Cleveland Translational ComponentU01AA021890 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI NAGY, LAURA E. · 2012 to 2017
$1.6MMechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01GM119174 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2017 to 2020
$1.2MMechanistic basis of exercise responses in liver diseaseR01DK133905 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2023 to 2025
$863kAHRQ HHS R01 HS026937NIAAA NIH HHS 3U01AA026976 - 03S1NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R01 AA021890NIAAA NIH HHS R01 AA028190NIAAA NIH HHS R01 AA030970NIAAA NIH HHS R01 DK113196NIAAA NIH HHS R01 GM119174NIAAA NIH HHS U01 AA021890NIAAA NIH HHS U01 AA 026976NIAAA NIH HHS U01 AA026976NIDDK NIH HHS R01 DK083414NIDDK NIH HHS R01 DK113196NIDDK NIH HHS R01 DK133905NIDDK NIH HHS U01 DK130180NIGMS NIH HHS R01 GM119174
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID38151782
PMCPMC10756636
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390